The aftermath of the Merck's HIV vaccine trial
<p>Abstract</p> <p>The recently released results of the Merck's Phase IIb "test-of concept" vaccine trials have shown no protection from HIV-1 infection in the vaccinated group compared with a control group vaccinated with placebo. The study was designed to test the...
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
BMC
2008-07-01
|
| Reeks: | Retrovirology |
| Online toegang: | http://www.retrovirology.com/content/5/1/56 |